← Leaderboards
James A Goodrich
Medical University Of South Carolina
$1,757,350
Attributed
$1,757,350
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $365K · FY2005–06$500K$375K$250K$125K$0
'05
'06
Funding mix
By agency
NIH$1,757,350 · 1
By mechanism
R24$1,757,350 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Maria F Lopes-Virella$3,980,090
- Narayan R Bhat$5,057,283
- Ayad A Jaffa$7,063,873
- Daping Fan$7,089,971
- Timothy J Lyons$5,303,277
Others in their field
Top investigators on “Acute Phase Protein”
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Ziad Nahas · Medical University Of South Carolina$22,722,368
- Neelum T Aggarwal · Rush University Medical Center$16,273,458
- Elizabeth Phillips · University Of Cape Town$15,913,564
- Scott J Hultgren · Washington University$14,378,041
- Athan Kuliopulos · Tufts Medical Center$13,148,245
Research focus
Acute Phase ProteinDisease /Disorder ModelInterleukin 6Low Density LipoproteinModel Design /DevelopmentTissue /Cell CultureCholesterolOvariectomyEstrogensFlavonesHormone TherapyCoronary DisorderImmunocytochemistryPostmenopauseSkinMiniature SwineSoybeansAtherosclerosisBlood PressureBody TemperatureCardiovascular Disorder RiskHot Flash
Grant awards (6)
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$175,786
R24 · FY2006 · RR · contact PI
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$151,000
R24 · FY2006 · RR · contact PI
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$365,000
R24 · FY2005 · RR
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$365,000
R24 · FY2004 · RR
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$346,971
R24 · FY2003 · RR
THE YUCATAN MICROPIG CARDIOVASCULAR MODEL OF MENOPAUSE$353,593
R24 · FY2002 · RR